69
Views
0
CrossRef citations to date
0
Altmetric
Lymphatic malignancies

Vascular endothelial growth factor expression in pediatric non-Hodgkin lymphoma: A prospective study

, , , , , , & show all
Pages 168-170 | Received 15 Sep 2015, Accepted 13 Mar 2016, Published online: 16 May 2016

References

  • Okur FV, Karadeniz C, Buyukpamukcu M, et al. Clinical significance of serum vascular endothelial growth factor, endostatin, and leptin levels in children with lymphoma. Pediatr Blood Cancer. 2010;55:1272–1277.
  • Salven P, Orpana A, Teerenhovi L, Joensuu H. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients. Blood. 2000;96:3712–3718.
  • Jørgensen JM, Sørensen FB, Bendix K, et al. Angiogenesis in non-Hodgkin's lymphoma: clinico-pathological correlations and prognostic significance in specific subtypes. Leuk Lymphoma. 2007;48:584–595.
  • Loges S, Clausen H, Reichelt U, et al. Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis. Clin Cancer Res. 2007;13:76–80.
  • Link MP, Shuster JJ, Donaldson SS, Berard CW, Murphy SB. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. N Engl J Med. 1997;337:1259–1266.
  • Reiter A, Schrappe M, Parwaresch R, et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage—a report of the Berlin-Frankfurt-Münster group. J Clin Oncol. 1995;13:359–372.
  • Reiter A, Schrappe M, Ludwig WD, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood. 2000;95:416–421.
  • Yang H-Q, Zhang R-H, Zhang Z-H, Wan C-C, Xia Y-J. [Plasma concentrations of vascular endothelial growth factor and tissue factor in children with acute lymphoblastic leukemia]. Zhongguo Dang Dai Er Ke Za Zhi Chin J Contemp Pediatr. 2007;9:526–528.
  • Dincaslan HU, Yavuz G, Unal E, et al. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients? Pediatr Hematol Oncol. 2010;27:503–516.
  • Avramis IA, Panosyan EH, Dorey F, Holcenberg JS, Avramis VI, Children's Oncology Group. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962. Clin Cancer Res. 2006;12:6978–6984.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.